LKFT
Galapagos N.V. Sponsored ADR
NASDAQ · Healthcare · Biotechnology · US
$28.49
−1.83%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.04x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.01x
- Net debt / EBITDA
- -0.24x
Liquidity & coverage
- Current ratio
- 32.82x
- Quick ratio
- 32.82x
- Cash ratio
- 31.85x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $2.6B
Cash & dividend
- FCF / debt
- -31.04x
- Cash flow / debt
- -30.32x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026